Gene · 25913
Papers2,597
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,597
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Male Germ Cell Telomeres and Chemical Pollutants. | Biomolecules | 2023 | 37238614 | PubTator, text mining | PubMed |
| Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population. | Nat Commun | 2023 | 37236969 | PubTator, text mining | PubMed |
| Role of telomere length in human carcinogenesis (Review). | Int J Oncol | 2023 | 37232367 | PubTator, text mining | PubMed |
Obesity and dyslipidemia are associated with partially reversible modifications to DNA hydroxymethylation of apoptosis- and senescence-related genes in swine adipose-derived mesenchymal stem/stromal cells. | Stem Cell Res Ther | 2023 | 37231414 | PubTator, text mining | PubMed |
| Non-canonical telomere protection role of FOXO3a of human skeletal muscle cells regulated by the TRF2-redox axis. | Commun Biol | 2023 | 37231173 | PubTator, text mining | PubMed |
| Sporadic parathyroid adenoma: an updated review of molecular genetics. | Front Endocrinol (Lausanne) | 2023 | 37223014 | PubTator, text mining | PubMed |
| Telomerase-targeted therapies in myeloid malignancies. | Blood Adv | 2023 | 37216228 | PubTator, text mining | PubMed |
| Genetic and clinical determinants of telomere length. | HGG Adv | 2023 | 37216007 | PubTator, text mining | PubMed |
| Skin Ageing: A Progressive, Multi-Factorial Condition Demanding an Integrated, Multilayer-Targeted Remedy. | Clin Cosmet Investig Dermatol | 2023 | 37192990 | PubTator, text mining | PubMed |
| Multiple Actions of Telomerase Reverse Transcriptase in Cell Death Regulation. | Biomedicines | 2023 | 37189709 | PubTator, text mining | PubMed |
| Size matters in telomere biology disorders ‒ expanding phenotypic spectrum in patients with long or short telomeres. | Hered Cancer Clin Pract | 2023 | 37189188 | PubTator, text mining | PubMed |
| Progression of liver disease and portal hypertension in dyskeratosis congenita and related telomere biology disorders. | Hepatology | 2023 | 37184208 | PubTator, text mining | PubMed |
| POT1 mutations cause differential effects on telomere length leading to opposing disease phenotypes. | J Cell Physiol | 2023 | 37183325 | PubTator, text mining | PubMed |
| Idiopathic pulmonary fibrosis and the role of genetics in the era of precision medicine. | Front Med (Lausanne) | 2023 | 37181377 | PubTator, text mining | PubMed |
| Genetics and Epigenetics in Complex Diseases. | Int J Mol Sci | 2023 | 37175893 | PubTator, text mining | PubMed |
| Identification of Novel Candidate Genes for Familial Thyroid Cancer by Whole Exome Sequencing. | Int J Mol Sci | 2023 | 37175550 | PubTator, text mining | PubMed |
| A Large-Scale Exome-Wide Association Study Identifies Novel Germline Mutations in Lung Cancer. | Am J Respir Crit Care Med | 2023 | 37167549 | PubTator, text mining | PubMed |
Clonal cytopenia of undetermined significance (CCUS)-associated reversion of donor-derived, transient αβ T-cell large granular clonal lymphocytosis, emerging post-transplant in a patient with a history of γδ T-cell large granular lymphocytic leukemia. | Cold Spring Harb Mol Case Stud | 2023 | 37160316 | PubTator, text mining | PubMed |
| Highlighting vulnerabilities in the alternative lengthening of telomeres pathway. | Curr Opin Pharmacol | 2023 | 37149932 | PubTator, text mining | PubMed |
| Telomere loss is accompanied by decreased pool of shelterin proteins TRF2 and RAP1, elevated levels of TERRA and enhanced glycolysis in imatinib-resistant CML cells. | Toxicol In Vitro | 2023 | 37149272 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/25913/papers?page=15